CVS Health Corp (CVS) : Fernwood Investment Management reduced its stake in CVS Health Corp by 14.12% during the most recent quarter end. The investment management company now holds a total of 47,460 shares of CVS Health Corp which is valued at $4,920,178 after selling 7,800 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on May 10, 2016.CVS Health Corp makes up approximately 4.97% of Fernwood Investment Management’s portfolio.
Other Hedge Funds, Including , Cls Investments boosted its stake in CVS in the latest quarter, The investment management firm added 3,617 additional shares and now holds a total of 11,835 shares of CVS Health Corp which is valued at $1,226,934. CVS Health Corp makes up approx 0.05% of Cls Investments’s portfolio.Intersect Capital boosted its stake in CVS in the latest quarter, The investment management firm added 1,016 additional shares and now holds a total of 3,789 shares of CVS Health Corp which is valued at $397,277. CVS Health Corp makes up approx 0.25% of Intersect Capital’s portfolio.Schwab Charles Investment Management Inc boosted its stake in CVS in the latest quarter, The investment management firm added 64,666 additional shares and now holds a total of 3,370,246 shares of CVS Health Corp which is valued at $353,370,293. CVS Health Corp makes up approx 0.46% of Schwab Charles Investment Management Inc’s portfolio.Augustine Asset Management Inc reduced its stake in CVS by selling 29,485 shares or 36.56% in the most recent quarter. The Hedge Fund company now holds 51,159 shares of CVS which is valued at $5,364,021. CVS Health Corp makes up approx 4.66% of Augustine Asset Management Inc’s portfolio.
CVS Health Corp opened for trading at $103.67 and hit $104.76 on the upside on Monday, eventually ending the session at $104.55, with a gain of 0.85% or 0.88 points. The heightened volatility saw the trading volume jump to 28,22,445 shares. Company has a market cap of $112,289 M.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 117 from a previous price target of $104 .Company shares were Reiterated by RBC Capital Mkts on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.